Chemical Intermediate Nsi-189 Powder CAS 1270138-40-3 Nootropics Nsi-189

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: API
• Certification: GMP, ISO 9001
• Suitable for: All
• State: Solid
• Purity: >99%
• Keyword: Nsi-189
• Sample: Available
• MOQ: Consult
• Mf: C22h30n4o
• CAS: 1270138-40-3
• Test Method: HPLC
• Transport Package: Aluminum Foil Bag/Paper Drum
• Specification: 99%
• Trademark: xinlu
• Origin: China
• Production Capacity: 100kg

Product Description

NSI-189 is a small molecule drug with clinical treatment for major depressive disorders and preclinical treatment for Angel-man syndrome, radiation-induced cognitive impairment, type 1 and type 2 diabetes, and stroke.

 

Product name:	NSI-189
Appearance:	Whte powder
CAS:	1270138-40-3
Purity:	99%
Grade Standard:	Medicine Grade

1. Stimulates Neurogenesis: NSI-189 promotes the growth and differentiation of new neurons (neurogenesis) in the brain, particularly in the hippocampus, a region crucial for memory and emotion.
2. Enhances Neuroplasticity: By increasing the expression of brain-derived neurotrophic factor (BDNF), NSI-189 enhances neuroplasticity, the brain's ability to form new connections and adapt to changes, supporting cognitive resilience.
3. Antidepressant-like Effects: Early research suggests that NSI-189 may exert antidepressant effects through mechanisms distinct from traditional antidepressants, potentially addressing treatment-resistant depression and promoting emotional well-being.

1. Neurodegenerative Disease Treatment: NSI-189 is being explored as a potential therapeutic for various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and depression with neurodegenerative features.
2. Cognitive Enhancement: Due to its ability to stimulate neurogenesis and neuroplasticity, NSI-189 is being investigated for its potential to enhance cognitive function, memory, and learning abilities in healthy individuals or those with mild cognitive impairment.
3. Clinical Trials: It is currently undergoing clinical trials to evaluate its safety, efficacy, and optimal dosing regimen for treating specific neurological conditions.

Related products

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Albendazole	54965-21-8	Mebendazole	31431-39-7
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
RU 58841	154992-24-2	cb-03-01	19608-29-8
Biotin	58-85-5	Biotinoyl tripeptide-1	299157-54-3
Finasteride	98319-26-7	Dutasteride	164656-23-9

Xi'an Xinlu Biotechnology Co., Ltd. is a high-end brand company focusing on the biomedical industry and integrating R&D, production and sales.  It has an independent R&D center, advanced laboratory equipment and a professional R&D team, a GMP standard production workshop, a complete set of internationally advanced assembly line equipment, a preparation workshop with a cleanliness level of 100,000, as well as sophisticated testing instruments and scientific testing methods, providing solid technical support for the production of high-quality products.  Through long-term R&D, production, and sales practices, it has formed its own unique product line, providing users with products of reliable quality at highly affordable prices.  We strictly control quality, ensure the stability of product quality in all aspects, and win the trust of customers with high quality and high-level development.